SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-18-001693
Filing Date
2018-03-08
Accepted
2018-03-08 16:07:16
Documents
85
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K s109144_10k.htm 10-K 923194
2 EXHIBIT 22.1 s109144_ex22-1.htm EX-22.1 1396
3 EXHIBIT 23.1 s109144_ex23-1.htm EX-23.1 2925
4 EXHIBIT 31.1 s109144_ex31-1.htm EX-31.1 9166
5 EXHIBIT 31.2 s109144_ex31-2.htm EX-31.2 9227
6 EXHIBIT 32.1 s109144_ex32-1.htm EX-32.1 4416
7 EXHIBIT 32.2 s109144_ex32-2.htm EX-32.2 4360
  Complete submission text file 0001615774-18-001693.txt   4479043

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE atos-20171231.xml EX-101.INS 708167
9 XBRL SCHEMA FILE atos-20171231.xsd EX-101.SCH 55610
10 XBRL CALCULATION FILE atos-20171231_cal.xml EX-101.CAL 69919
11 XBRL DEFINITION FILE atos-20171231_def.xml EX-101.DEF 156223
12 XBRL LABEL FILE atos-20171231_lab.xml EX-101.LAB 396525
13 XBRL PRESENTATION FILE atos-20171231_pre.xml EX-101.PRE 297666
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35610 | Film No.: 18676533
SIC: 2834 Pharmaceutical Preparations